#USA #Delray Beach #MarketsandMarkets #IVD Raw Materials #Diagnostic Assays

IVD Raw Material Market Forecast to Reach $31.1 Billion by 2031

According to a recent report from MarketsandMarkets™, the IVD (In Vitro Diagnostics) Raw Material Market is expected to expand significantly from $21.5 billion in 2026 to $31.1 billion by 2031. This impressive growth translates to a Compound Annual Growth Rate (CAGR) of 7.7% over the forecast period. The market encapsulates various biological and chemical components utilized in developing and manufacturing diagnostic assays, including essential items such as antibodies, antigens, recombinant proteins, enzymes, nucleic acids, buffers, and other specialty reagents.

Key Trends Influencing Market Growth

The increasing prevalence of chronic and infectious diseases is one of the key drivers behind this market expansion. As healthcare technology evolves, the demand for early and accurate disease diagnoses is on the rise, stimulating the adoption of molecular diagnostics, immunodiagnostics, and point-of-care testing solutions. Moreover, the growth in healthcare infrastructure and rising investments in diagnostic technologies are bolstering the market for high-quality IVD raw materials, particularly in emerging economies.

Additionally, the ongoing advancements in diagnostic platforms and the focus on personalized medicine are pushing for the adoption of innovative, high-performance raw materials within the global diagnostics industry.

Product Segmentation and Market Share

As per the anticipated trends, the antibodies segment will likely maintain a leading position in the market, accounting for about 34.5% market share in 2025. Antibodies are crucial in numerous diagnostic technologies, especially in immunoassays, where they serve as primary agents to detect and quantify disease-specific biomarkers. Their importance is amplified in applications related to infectious diseases, oncology, cardiac markers, and autoimmune diseases.

Furthermore, by supply source, in-house manufacturing will dominate the scene, comprising 66.1% of the market share in 2025, illustrating the growing trend of organizations seeking to control the quality and performance of their diagnostic materials.

Rising Demand for Point-of-Care Testing Solutions

The point-of-care testing segment is projected to experience the highest growth rate in the IVD raw material market. This segment's growth is driven by the increasing demand for rapid, decentralized, and user-friendly diagnostic solutions. The adoption of lateral flow assays and portable diagnostic devices is on the rise, with a specific focus on specialized raw materials like antibodies and detection reagents.

Healthcare accessibility and the urgency of early disease detection are additional factors contributing to the expansion of this segment.

Regional Insights

The report highlights that the Asia Pacific region is poised to experience the highest growth rate from 2026 to 2031. Key markets within this region include China, Japan, and India, each contributing to the increasing demand for quality IVD raw materials. China's booming diagnostic manufacturing sector and Japan's advanced healthcare system support this upward trend, while India's expanding laboratory network reinforces market growth.

Leading Companies in the IVD Raw Material Sector

Key players shaping the future of the IVD raw material market include Merck KGaA, Thermo Fisher Scientific, Medix Biochemica, and many others. These leading companies are at the forefront of innovations and improvements in diagnostic capabilities.

As the IVD raw material market continues to grow, it becomes evident that the future of diagnostics will rely heavily on the development and availability of high-quality raw materials. The evolving landscape of healthcare calls for consistent advancements in diagnostic technologies, ensuring that the industry meets rising demands across various healthcare and research applications.

In summary, the IVD raw material market is on the brink of significant transformation and growth, driven by technological advancements and an ever-increasing need for effective diagnostic tools, all crucial elements leading to improved patient outcomes in healthcare.